Johnson & Johnson has begun vaccinating participants between 12 and 17 years old in its ongoing clinical trial for its COVID-19 vaccine, according to a company statement Friday.
“The COVID-19 pandemic has had a profound impact on adolescents, not just with the complications of the disease, but with their education mental health, and wellbeing,” said Dr. Paul Stoffels, chief scientific officer at Johnson & Johnson. “It is vital that we develop vaccines for everyone, everywhere, to help combat the spread of the virus with the goal to return to everyday life.”
The news follows the release of a Pfizer study that found its COVID-19 vaccine with German partner BioNTech was proven safe and effective for kids ages 12 to 15. The company also announced beginning trials in children under 12 years old.
In a separate company study, researchers found volunteers remained more than 90% protected against symptomatic COVID-19 and even better protected against severe disease six months after getting a second dose of the Pfizer-BioNTech vaccine. It also protects against the P.1 variant, first identified in Brazil.
Also in the news:
►The coronavirus variant discovered in California triggered a less effective immune response from the vaccine, a study published Thursday said.
►Michigan, where COVID-19 is surging more than in any state, on Thursday reported its first confirmed case of a coronavirus variant that was initially identified in Brazil.
►The Alabama prison system, which ranks sixth in the country for COVID-19 deaths, announced Thursday that it will begin vaccinating inmates.
►Nevada lawmakers are considering sending mail-in ballots to all active voters in future elections after passing a law last summer that directed election officials to do so to prevent the coronavirus from spreading at polling places.
►Italy Prime Minister Draghi issued a decree Wednesday requiring health care workers to be vaccinated and allowing employers to suspend workers without pay who refuse to get vaccinated. – NYTimes
📈 Today’s numbers: The U.S. has over 30.53 million confirmed coronavirus cases and more than 553,210 deaths, according to Johns Hopkins University data. The global totals: 129.47 million cases and 2.82 million deaths. More than 200.49 million vaccine doses have been distributed in the U.S. and 153.63 million have been administered, according to the CDC.
📘 What we’re reading: What can I do if I’m vaccinated against COVID-19, but my child isn’t? Here are activities health experts say are safe.
The Centers for Disease Control and Prevention said Americans who are fully vaccinated against COVID-19 can resume travel at low risk to themselves, but the agency is still not recommending travel given rising case counts.
CDC Director Rochelle Walensky, who earlier this week issued an urgent plea to limit travel due to fears of another COVID surge, said Friday the new guidance is based on studies showing the “real-world” effectiveness of COVID-19 vaccines.
Vaccinated travelers no longer have to follow the CDC’s recommendations to get a COVID-19 test before and after travel unless required by the destination. They still need to wear masks and take other precautions.
For international travel, vaccinated passengers still must abide by a CDC order, issued in January, requiring a negative COVID test to board flights to the United States, and should get another test three to five days after arriving.
Despite the new guidance, Walensky said during a White House briefing that the CDC is not reversing its advice to avoid nonessential travel during the pandemic, vaccinated or unvaccinated
Asked how that squares with the announcement that vaccinated Americans can safely travel, she said: “Our guidance is silent on recommending or not recommending fully vaccinated people travel,” she said. “Our guidance speaks to the safety of doing so. If you are vaccinated, it is lower risk.”
– Dawn Gilbertson
Moderna can put 50% more vaccine dosage in each vial, the Food and Drug Administration said Thursday.
The company has been manufacturing 10 dose vials, but the FDA’s decision allows the company to put up to 15 doses in each vial, a move that allows Moderna to speed up shipments and get more shots in arms.
The FDA is also allowing 11 doses to be extracted out of current 10 dose vials.
“Both of these revisions positively impact the supply of Moderna COVID-19 Vaccine, which will help provide more vaccine doses to communities and allow shots to get into arms more quickly. Ultimately, more vaccines getting to the public in a timely manner should help bring an end to the pandemic more rapidly,” said Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research.
British regulators identified 30 blood clot events from people who received the AstraZeneca COVID-19 vaccine, which is 25 more cases than previously reported on March 18, according to a statement from the Medicines and Healthcare products Regulatory Agency Thursday.
The news comes as countries adopt precautionary measures to restrict the use of AstraZeneca’s vaccine. Most recently, Germany recommended Thursday that people under 60 years old who have received their first shot should receive a different vaccine for their second dose, according to Reuters report.
The AstraZeneca COVID-19 vaccine has yet to receive authorization in the United States and Dr. Anthony Fauci, the nation’s leading expert in infectious diseases, told Reuters the U.S. may not even need it.
“That’s still up in the air,” he said. “My general feeling is that given the contractual relationships that we have with a number of companies, that we have enough vaccine to fulfill all of our needs without invoking AstraZeneca.”
Yacht clubs, golf courses, gated communities: Florida’s pop-up vaccine clinics raise ethical concerns
When Florida threw open the door for seniors to get COVID-19 vaccines, hundreds camped out overnight, some bundled up in lawn chairs in the January cold to score a shot. Thousands more waited in digital lines for their number to come up in county-run vaccine pools. But for some lucky Floridians, getting a vaccine was as easy as hopping in their golf carts and rolling down to the clubhouse.
A USA TODAY Network analysis of state and local government records, news reports and information from private developers found at least 150 communities that landed vaccine pop-ups or priority access to doses. Data provided by the state is incomplete so there likely are many more. Read the full story.
– Zac Anderson and Josh Salman, Sarasota Herald-Tribune
Major League Baseball’s opening day was waylaid by the postponement of the nationally televised Washington Nationals-New York Mets opener because of COVID-19 issues with the Nationals. The team was dealt a blow when it learned a player tested positive, resulting in four more players and a staff member isolated for the opener after contact tracing.
“They did some additional testing and without getting into the details, it became clear that the safest course for both teams was to take advantage of the off day tomorrow,” MLB commissioner Rob Manfred said in an ESPN interview.
– Gabe Lacques